Endocrine Flashcards
Criteria for metabolic syndrome (5)
3 of the following:
1) Waist circumference (>/= 102 male, female 88)
2) Triglycerides >/= 1.7 mmol/L
3) HDL < 1.0 men or <1.3 women
4) BP >/= 130/85 mm Hg
5) FBG >/= 5.6 mmol/L
What is most important risk factor for insulin resistance and DM
Obesity
Hormones involved in insulin resistance
1) Amylin - Decreased in DM I & II.
Fx - delay gastric emptying, decrease postprandial glucagon, and increases satiety
2) Ghrenlin - Decreased
Fx - produced by stomach and pancreas to regulate food intake and insulin levels
3) Incretins (GLP-1) - Decreased activity
Fx - released by GI tract in response to food. Stimulate pancreas to produce more insulin, slow emptying, promote satiety. Normally broken down by DPP-4.
4) Glucagon - increased
Fx - glycogenolysis and gluconeogenesis
Somogyi effect
Decreased BG level at night that may lead to increase in morning BG
Dawn phenomenon
Early morning rise in BG d/t GH, cortisol and catecholamines NOT preceded by hypoglycemia
Causes of blurred vision in DM
Macular edema
Hyperglycemia
Biguanide
Ex. Metformin
MOA - increase hepatic glucoses production, increase glucose uptake in muscles Pros - no weight gain, minimal hypoglyemia
+ cheap, first line treatment DM II
Negatives - GI SE, LACTIC ACIDOSIS, CI in liver and renal insufficiency and cardiac failure
Sulfonylurea
MOA - Increase insulin secretion from pancreatic beta cells
Ex. glipizide, glimepiride, glyburide (highest risk of hypoglycemia)
+ cheap
Negative - hypoglycemia, weight gain, skin rash
Meglinitides
MOA - Increased insulin secretion from beta cells
Ex. repaglinide, nateglinide
+ dosing before meals, decrease postprandial glucose
Negative - HYPOGLYCEMIA, wt gain, frequent dosing
TZD
MOA - Increase insulin sensitivity
Ex. pioglitazone, rosiglitazone
+ increased HDL, decrease triglycerides
Negative - weight gain, edema/HF, bone fractures, increased LDL, ?MI
DPP-4 inhibitors
MOA - Increased insulin secretion, decreased glucagon secretion
Ex. “gliptin”, saxagliptin (increased risk of HF)
+ once daily dosing, well tolerated
Negative - urticaria/angioedema, cost, increased risk of hypoglycemia, pancreatitis and ? HF hospitalizations
GLP-1 agonist
Increased insulin secretion, decrease glucagon secretion, slow gastric emptying, increased satiety
Ex. “glutide”/”tide”
+ decreased postprandial glucose, well tolerated, liraglutide and semaglutide improve CV outcomes in older people with diabetes
Negative - GI upset, increased HR, pancreatitis, avoid in CKD, CI - DKA, cirrhosis and intestinal diseases
Glucosidase inhibitors
Ex. acarbose, miglitol
MOA - Slows intestinal carbohydrate digestion and absorption
+ decrease postprandial glucose, minimal hypoglycemia
Negative - SE abd pain and flatulance, CI in cirrhosis, frequent dosing schedule
SGLT-2 Inhibitors
Decreased glucose reabsorption in proximal tubule, increased urinary glucose excretion
+ once daily dosing, decrease BP. empagliflozin/canagliflozin has CV benefit
Caution renal insufficiency, GU infections, hyperkalemia, orthostatic hypotension, pancreatitis
Ex. “gliflozin”
A1C target for functionally independent
= 7.0%
A1C target for functionally dependent frailty index 4-5)
<8.0%
A1C target for frail and/or dementia
<8.5%
BP target for functionally independent and life expectancy > 10 years
<130/80 mm Hg
Target LDL
<2.0 mmol/L or 50% reduction from baseline
Frailty definition
3 or more of the following criteria are present:
- unintentional weight loss (>4.5 kg in the past year)
- self-reported exhaustion
- weakness (diminished grip strength)
- slow walking speed
- low physical activity
True/False
In older people with obesity and type 2 diabetes, the principal metabolic defect is resistance to insulin-mediated glucose disposal, with insulin secretion being relatively preserved
True
True/False
Diabetes screening is beneficial in asymptomatic individuals over the age of 80
False
True/False
A1C is less reliable in older adults due to the effect of comorbid conditions
True
General screening for DM, average risk adults
Q3 years starting at age 40
General screening for DM, with risk factors or high CANRISK score
Q6-12 months at any age
Risk factors for DM
- 1st degree Fmhx, high-risk ethnic group,
- Hx of prediabetes, hx of GDM, hx of macrosomic infant
- DM associated end organ damage (retino, nephropathy etc)
- Vascular RF: dyslipids, HTN, inc wt, abdo obesity, smoking
- Associated conditions: hx of pancreatitis, PCOS, acanthosis nigricans, gout, NAFLD, psych d/o, HIV, OSA, CF
- Meds: glucocorticoids, atypical antipsychotics, HIV meds, statins, anti-rejection meds,
Diagnosis of DM
- A1C > 6.5
- FBG > 7.0
- GTT > 11.1
- If asymptomatic 2 tests in diabetic range necessary for dx
- If symptomatic only 1 test required
True/False
A1C can be used in isolation to diagnose DM in older adults
False
Prediabetes diagnosis
- FBG: 6.1 - 6.9
- A1C: 6.0 - 6.5
Treatment: A1C < 1.5% above target
Lifestyle x 3 months, then if not at target start/increase metformin
Treatment A1C >/= 1.5% above target
Start metformin immediately, consider 2nd agent
Treatment if symptomatic hyperglycaemia with DM
Initiate insulin +/- metformin
A1C target for end of life
Do not measure, avoid symptomatic highs/lows
Low risk medications to prevent hypoglycemia
metformin, GLP1s, DDP4s, SGLT2s, TZD, alpha-glucosidase inhibitors
High risk medications for hypoglycemia
insulins, sulfonylureas, meglitinides (less risk than sulfonylureas)
When treating older adult which of the following should be considered:
a) use DPP-4 instead of sulfonylureas
b) treat with ½ of normal dose of sulfonylurea
c) use gliclazide or glimepiride instead of glyburide
d) opt for meglitinides instead of glyburide to prevent hypoglycemia
e) all of the above
E
What test can be used to predict cognitive and physical capability to inject insulin?
Clock drawing test
Geriatric monitoring (4 M’s)
Mentation - memory and mood
Mobility - fall, visual problems, neuropathy, weakness, BP
Medication - polypharm
Matters most - goals, MOST
Microvascular complications
Nephropathy
Retinopathy
Peripheral neuropathy
ANS dysfunction
Macrovascular complications
Coronary, carotid, PVD
SADMANs Medications
S - sulphonylureas
A - ACE-I
D - diuretics
M - metformin
A - ARBs
N - NSAID
S - SGLT-2 inhibitors
Antihyperglycemic drugs for CVD if GFR > 30
Empagliflozin (Grade A)
Liraglutide (Grade A)
Canagliflozin (Grade C)
ABCDESSS of Diabetes
A1C targets
BP targets
Cholesterol targets
Drugs for CVD
Exercise goals and healthy eating
Screening for complications
Smoking cessation
Self-management/Stress
Screening ECG for DM
Q3-5 years
Screening feet in DM
Monofilament yearly or > if abN
Screening for kidney dysfunction
eGFR and ACR yearly
Screening for retinopathy
Q 1-2 years with optometrist/opthamologist
4 A’s of smoking cessation
- Ask - Identify and document tobacco use
- Advise - to quit.
- Assess - readiness to quit
- Assist - counselling/pharmacotherapy
- Arrange - follow up
Which of the following are presenting symptoms of DM specific to older adults:
a) dehydration, dry mouth
b) thin body habitus
c) P, P, P’s
d) neuropathy
e) incontinence
f) hyperosmolar nonketotic coma
g) all of the above
A, D, E, F
Thin body habitus is not specific to older adult population and is seen in younger to middle adults. Dehdration (d/t decreased thirst sensation and delayed fluid intake). Less glycosuria (d/t inc renal threshold for glucose with age). Exacerbation of common age-associated syndromes (pain, incontinence, cognitive impairment depression, falls)
What sensations are commonly lost in peripheral neuropathy
Loss of pain, temperature, and vibration sensation is more common than motor involvement
Describe autonomic neuropathy S&S
- delayed gastric emptying, diabetic diarrhea, altered bladder fx, impotence, orthostatic hypoTN
Monofilament testing requires testing area 2 times with monofilament and one mock test (no contact). Which of the following indicate impaired sensation?
a) ⅔ right
b) ⅓ wrong
c) ⅔ wrong
d) none of the above
C
True/False
T3 is 5 x more active than T4
False. T3 is 10 x more active
Thyroid hormone effect on body (CVS, metabolism)
Increase CO, HR, RR
Increase 02 demand
Increase glucose absorption, gluconeogenesis, glycogenolysis, lipolysis, and protein synthesis
Increase BMR
Charcot arthropathy. characterized by collapse of the arch of the midfoot, which is replaced by a bony prominence (arrow). Several factors contribute to this painless condition, including small muscle wasting, decreased sensation, and maldistribution of weightbearing.
Wolff Chaikoff effect
++ iodine = low levels thyroid hormone - hypothyroidism
Jod Basedow effect
If exposed to large/ normal amounts of iodine- results in ++ thyroid hormone secretion / hyperthyroidism
True/False
Elevated lipids OR depression are indications for checking TSH in elderly
True
What happens with T4 production and clearance in the older adult? How is T3 affected in this population?
T4 - reduced production, reduced clearance = unchanged
T3 - unchanged
Most common cause of hypothyroidism?
Hashimotos disease/ Chronic autoimmune thyroiditis
Less common causes of hypothyroidism
Radiation, surgical removal, idiopathic, excess iodine, meds - amiodarone, lithium, radio contrast
True/False
Hyper/hypothyroidism can be diagnosed in states of acute illness
False
Diagnosis in presence of acute illness should only be made if thyroid lab abnormalities continue 2 weeks after sickness resolution